Germenis AE

No ORCID on file · 2 papers in corpus

2025

Hereditary Angioedema with Normal C1 Inhibitor: an Updated International Consensus Paper on Diagnosis, Pathophysiology, and Treatment.

Clinical reviews in allergy & immunology ·doi:10.1007/s12016-025-09027-4

Hereditary angioedema (HAE) has been recognized for almost 150 years. The newest form of HAE, where C1 inhibitor levels are normal (HAE-nC1INH), was first described in 2000. Over the last two decades, new types of apparent non-mast cell-med…

2024

Hereditary angioedema with normal C1 inhibitor associated with carboxypeptidase N deficiency.

The journal of allergy and clinical immunology. Global ·doi:10.1016/j.jacig.2024.100223

BackgroundHereditary angioedema (HAE) is a potentially life-threatening disorder characterized by recurrent episodes of subcutaneous or submucosal swelling. HAE with normal C1 inhibitor (HAE-nC1-INH) is an underdiagnosed condition. Although…